Journal of Dental Research 2017 Year End Review

I am pleased to provide the annual report as Editor-in-Chief for the Journal of Dental Research. This summary gives a progress report on the JDR over the past year acknowledging the great support of our readers, authors, reviewers and editorial board members. I believe that the journal has continued to improve, expand, and evolve as a leading source of scientific advances in the dental, oral, and craniofacial sciences.  The JDR is currently ranked # 1/90 journals in Dentistry, Oral Surgery & Medicine for EigenfactorÔ Score at 0.02225 and #2 in 2-year impact factor at 4.755, the 4th consecutive year that the journal has exceeded 4 for SIF.  Our 5-year SIF is 5.016. The JDR generated 17,285 citations from 233 total articles during 2015-16, an all-time high number. I feel the journal remains strong not only in these metrics, but also in other important measures including full-text downloads, page views, article influence score well above competing journals in dentistry (See Figure 1).

The journal owes much of this success to a team effort of Dr. Christopher Fox, Denise Streszoff, Kourtney Skinner, and Lily Knol at the JDR Headquarters in Alexandria. The editors are also fortunate to be supported by the capable staff at SAGE Publishing, including, Paulina Klein, Andrew Thompson, and Melinda Keramat, who have done a fine job in developing a strong working relationship among the Editors, the IADR/AADR Central Offices and SAGE to sustain the excellence of JDR.  Mr. Jim Sugai as the local editorial assistant at the University of Michigan closely supports us on the day-to-day administration of the JDR with the careful management of manuscript page proofs with the authors, our office, and SAGE. We are also highly fortunate for the outstanding dedication of the associate editors: Professors Dana Graves, Jack Ferracane, Jessica Lee, Jacques Nör, Joy Richman, Gustavo Garlet, and our newest editor, Nick Jakubovics. I feel we continue to have a high degree of mutual respect and collaboration to make the difficult manuscript decisions as JDR’s acceptance rate remains at ~10-15% on research reports suggesting the high quality of submissions that we receive.

Figure 1. JDR Leads all Dental Journals for combined Impact Factor and Total Citations demonstrating strong balance in the oral health sciences. Source: Wiley.

Figure 1. JDR Leads all Dental Journals for combined Impact Factor and Total Citations demonstrating strong balance in the oral health sciences. Source: Wiley.

The September 2017 author survey results showed that the JDR performs very well in author satisfaction metrics.  The responses for the 18 questions showed the JDR authors were mainly either “satisfied” or “very satisfied” for all measures (see corresponding survey results).  Of the 41 JDR authors responding to the survey, 88% (36) said that the journal was their first choice, and 85% (35) perceive the journal as a top tier title.

The following are some highlights of progress of the JDR for 2017:

  1. Manuscript Processing. The most recent data on time of submission to first decision is efficient, with the time being 12.35 days for original submissions and 11.7 days for revised submissions. The time to publication has been well sustained over the past 7-1/2 years and remains highly competitive within the scholarly publication field. The numbers of papers triaged remains close to ~60% at entry and 50% rejection at revision to enable submitting authors a quick turnaround time to identify other venues for their research  (Figure 2).
    Figure 2. Original manuscript decisions for the JDR from January 1 – November 3, 2017. The graph shows of the 1,324 manuscript decisions made, over half are either rejected or transferred to JDR-CTR to continue to build the clinical journal. To date, 193 manuscripts have been accepted for publication in the JDR and Advances in Dental Research.

    Figure 2. Original manuscript decisions for the JDR from January 1 – November 3, 2017. The graph shows of the 1,324 manuscript decisions made, over half are either rejected or transferred to JDR CTR to continue to build the clinical journal. To date, 193 manuscripts have been accepted for publication in the JDR and Advances in Dental Research.

    Our manuscript processing efficiency is due to several factors including our editors, excellent editorial board/referees, journal staff, and the robust Scholar One/SAGEtrack manuscript platform. The strong workflow after a manuscript has been accepted has resulted in one of the most rapid acceptance to online and print publication in the oral health sciences (online available in ~20 working days, and print publication in 3-4 months from acceptance).

    Figure 3. Article Types submitted to the Journal of Dental Research. Of the 1,401 manuscripts submitted and decided from January 1, through November 3, 2017, 1,147 of the papers were research-type articles. Clinical Reviews represent the next most common submission type at 87 manuscripts received in 2017 so far.

  2. Manuscript Submissions and Global Institutional Reach. The JDR remains attractive for manuscript submissions of both original reports and reviews. Figure 3 displays the categories of submissions received by the journal offices, mostly research reports in the biological, biomaterials/bioengineering and clinical disciplines. The access of the JDR has been strong through SAGE’s partnership and promotion of Journal content through a variety of outlets such as HINARI (free access of JDR to libraries in the developing world).  The financial picture for the JDR remains strong (please see corresponding budget report), while also allowing ready access of JDR content globally.
  3. Promotion of JDR We have dedicated efforts on multiple press releases related to JDR manuscripts.  We generally have a perspective article or editorial co-publish on a particular paper of interest on a bi-monthly basis.  In 2017, multiple press releases were published relevant to journal publications or editors: See:
    The IADR Global Headquarters office through support by Elise Bender and Denise Streszoff disseminate press releases that go to a variety of media outlets. I also provide annual highlights on issues or specific content on the JDR Blog site. The above demonstrates the journal’s strong commitment to the promotion of science to the scientific, clinical and lay communities to engage interest by these constituencies on JDR research. We remain very active in promoting JDR research directly by the journal or in collaboration with JDR authors directly with the global headquarters.The editors have made for good opportunities for pod-casting, video and other online materials for JDR subscribers that we continue to growth. We have increased podcasting and have enlisted many of the Associate Editors and Guest Editors to co-moderate podcasts.  We had multiple podcasts in 2017 on topics such as a Salivary Proteomics and the Zika Virus, the Special Issue on Orofacial Clefting, the Global Burden of Oral Conditions, and NIH funding to US Dental Schools moderated by JDR Editors and selected IA/AADR Leadership: online usage of the journal remains strong and continues to grow.  Table 1 displays the online usage of the JDR in 2015 and 2016 showing strong interest from JDR stakeholders through electronic measures of article usage.

    Table 1. Online Usage Statistics for JDR comparing last Two Complete Years

  4. Publication of Advances in Dental Research e-supplements
    The Advances in Dental Research Publication continues to be a good publication outlet for the AADR and IADR for the dissemination of research, particularly as a part of workshops and symposia.  Since 2010, we have published 12 e-supplements to the ADR.  For 2018, we have 2 Advances e-Supplements that are already scheduled for publication.  The first is planned for February is the 3rd International Conference on Novel Anticaries and Remineralizing Agents (ICNARA 3) guest edited by Margherita Fontana.  The second will be a part of the IADR Satellite Symposium held at the San Francisco 2017 IADR entitled Guidelines for fluoride intake — are they appropriate?” guest edited by Andrew Rugg-Gunn.
  5. JDR Clinical & Translational Research for Expanded Clinical Content.JDRCTR Banner
    The JDR continues to emphasize the importance of the publication of clinical works, while working diligently to promote the success of the new journal through its Editor-in-Chief, Dr. Jocelyne Feine.  The Editorial team of the JDR remains very supportive of Dr. Feine as a strong champion for the new journal with a vision that provides a good opportunity for investigators wanting to consider this ­­­­journal venue.  The JDR Editorial leadership has interacted with Professor Feine very well in the transfer of papers that cannot be published in the JDR for consideration in JDR CTR. We have a strong working relationship with Dr. Feine that has led to a beneficial synergy between the journals to greatly expand clinical content for the IADR research community.
  6. JDR Planning for 2018: Special Issues in the Journal.   2017 was the second year we moved to 13 main issues of the JDR to incorporate the use of special issues. In October 2017, we published our 4th special issue, this one entitled Orofacial Clefting, Craniofacial, and Dental Anomalies. This peer-reviewed special issue provided a state-of-the-art issue on the biology, genetics, diagnosis and therapy for malformation of the dental, oral and craniofacial complex co-guest edited by Drs. Joy Richman and Brian Schutte.  We also performed a podcast on the special issue that linked to the insightful editorial entitled: “Face Forward: Gene Variants, Pathways, and Therapies for Craniofacial Anomalies.”

    We have a new call for manuscripts on another special issue on head and neck cancer that has recently closed for submissions.  This special issue will be co-guest edited by Dr. Silvio Gutkind of UC-San Diego and Dr. Jacques Nör. This special issue will highlight the latest developments in the field of head and neck cancer, including the role of HPV in the etiology of head and neck squamous cell carcinoma (HNSCC), the use of novel immunotherapies in the treatment of HNSCC, and new advancements in the mechanistic understanding and treatment of salivary gland malignancies. The issue will be of interest to researchers in the field of head and neck cancer, surgeons, physicians, and dental practitioners. Basic, translational, and clinical investigations that are focused on the mechanisms underlying the pathobiology of HNSCC and salivary gland cancer, cancer stem cells, biomarkers, and new therapies were encouraged.  New methods and technologies developed for the mechanistic studies of head and neck malignancies are also being considered.

I thank the readers and authors of the JDR for their continued support. The journal has gone through significant change over the past years and I have always felt the strong level of support to help me best serve our associations. I consider this position an honor and a privilege to play a part in the direction of our JDR. I will continue to work diligently alongside our talented editors, staff, authors and readership to continue to innovate and preserve the outstanding legacy the journal has enjoyed over near a century.

Yours respectfully,

William V. Giannobile
University of Michigan, USA
Journal of Dental Research